FDA panel to discuss raxibacumab for anthrax

FDA's Anti-Infective Drugs Advisory Committee will meet on Nov. 2 to discuss a BLA from Human Genome Sciences Inc. for raxibacumab to treat inhalational anthrax. The human mAb against Bacillus anthra...